Smith GT - Search Results

1

The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma.

Kabalka GW, Nichols TL, Smith GT, Miller LF, Khan MK, Busse PM. Kabalka GW, et al. Among authors: smith gt. J Neurooncol. 2003 Mar-Apr;62(1-2):187-95. doi: 10.1007/BF02699944. J Neurooncol. 2003. PMID: 12749713

2

Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.

Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CP, Roberts TG, Reddy NK, Buonocore E, Hübner KF. Kabalka GW, et al. Among authors: smith gt. J Nucl Med. 1997 Nov;38(11):1762-7. J Nucl Med. 1997. PMID: 9374349 Free article.

3

Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.

Nichols TL, Kabalka GW, Miller LF, Khan MK, Smith GT. Nichols TL, et al. Among authors: smith gt. Med Phys. 2002 Oct;29(10):2351-8. doi: 10.1118/1.1507780. Med Phys. 2002. PMID: 12408309

4

Positron Emission Tomography (PET) with 1-Aminocyclobutane-1-[(11)C]carboxylic Acid (1-[(11)C]-ACBC) for Detecting Recurrent Brain Tumors.

Hübner KF, Thie JA, Smith GT, Kabalka GW, Keller IB, Kliefoth AB, Campbell SK, Buonocore E. Hübner KF, et al. Among authors: smith gt. Clin Positron Imaging. 1998 Jun;1(3):165-173. doi: 10.1016/s1095-0397(98)00010-7. Clin Positron Imaging. 1998. PMID: 14516591

5

Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).

Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocore E. Hubner KF, et al. Among authors: smith gt. Gynecol Oncol. 1993 Nov;51(2):197-204. doi: 10.1006/gyno.1993.1272. Gynecol Oncol. 1993. PMID: 8276294 Clinical Trial.

6

Detection of overexpressed COX-2 in precancerous lesions of hamster pancreas and lungs by molecular imaging: implications for early diagnosis and prevention.

Schuller HM, Kabalka G, Smith G, Mereddy A, Akula M, Cekanova M. Schuller HM, et al. ChemMedChem. 2006 Jun;1(6):603-10. doi: 10.1002/cmdc.200500032. ChemMedChem. 2006. PMID: 16892400

7

2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography sensitivity to serum glucose: a survey and diagnostic applications.

Thie JA, Smith GT, Hubner KF. Thie JA, et al. Among authors: smith gt. Mol Imaging Biol. 2005 Sep-Oct;7(5):361-8. doi: 10.1007/s11307-005-0018-z. Mol Imaging Biol. 2005. PMID: 16228119

8

Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.

Hübner KF, Buonocore E, Gould HR, Thie J, Smith GT, Stephens S, Dickey J. Hübner KF, et al. Among authors: smith gt. Clin Nucl Med. 1996 Dec;21(12):941-9. doi: 10.1097/00003072-199612000-00005. Clin Nucl Med. 1996. PMID: 8957608

9

A weight index for the standardized uptake value in 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.

Thie JA, Hubner KF, Isidoro FP, Smith GT. Thie JA, et al. Among authors: smith gt. Mol Imaging Biol. 2007 Mar-Apr;9(2):91-8. doi: 10.1007/s11307-006-0068-x. Mol Imaging Biol. 2007. PMID: 17205367

10

Linear least squares compartmental-model-independent parameter identification in PET.

Thie JA, Smith GT, Hubner KF. Thie JA, et al. Among authors: smith gt. IEEE Trans Med Imaging. 1997 Feb;16(1):11-6. doi: 10.1109/42.552051. IEEE Trans Med Imaging. 1997. PMID: 9050404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters